212 related articles for article (PubMed ID: 11337356)
1. Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.
Kamarashev J; Burg G; Mingari MC; Kempf W; Hofbauer G; Dummer R
Am J Pathol; 2001 May; 158(5):1593-8. PubMed ID: 11337356
[TBL] [Abstract][Full Text] [Related]
2. In situ detection of activated cytotoxic cells in follicular lymphomas.
Leger-Ravet MB; Devergne O; Peuchmaur M; Solal-Celigny P; Brousse N; Gaulard P; Galanaud P; Emilie D
Am J Pathol; 1994 Mar; 144(3):492-9. PubMed ID: 7510456
[TBL] [Abstract][Full Text] [Related]
3. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
[TBL] [Abstract][Full Text] [Related]
4. Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entity.
Mukai HY; Hasegawa Y; Kojima H; Okoshi Y; Takei N; Yamashita Y; Nagasawa T; Mori N
Mod Pathol; 2002 Nov; 15(11):1131-9. PubMed ID: 12429791
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
8. Expression of cytotoxic molecules in intestinal T-cell lymphomas. The German Study Group on Intestinal Non-Hodgkin Lymphoma.
Daum S; Foss HD; Anagnostopoulos I; Dederke B; Demel G; Araujo I; Riecken EO; Stein H
J Pathol; 1997 Jul; 182(3):311-7. PubMed ID: 9349234
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
11. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis.
Cherin P; Herson S; Crevon MC; Hauw JJ; Cervera P; Galanaud P; Emilie D
J Rheumatol; 1996 Jul; 23(7):1135-42. PubMed ID: 8823683
[TBL] [Abstract][Full Text] [Related]
13. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
[TBL] [Abstract][Full Text] [Related]
14. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
[TBL] [Abstract][Full Text] [Related]
15. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of KIR/NKAT2 and CD94 molecules on decidual and peripheral blood CD56bright and CD56dim natural killer cell subsets.
Eidukaite A; Siaurys A; Tamosiunas V
Fertil Steril; 2004 Mar; 81 Suppl 1():863-8. PubMed ID: 15019821
[TBL] [Abstract][Full Text] [Related]
17. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ
J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136
[TBL] [Abstract][Full Text] [Related]
18. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.
Vermeer MH; van Doorn R; Dukers D; Bekkenk MW; Meijer CJ; Willemze R
J Clin Oncol; 2001 Dec; 19(23):4322-9. PubMed ID: 11731515
[TBL] [Abstract][Full Text] [Related]
19. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas.
Haedicke W; Ho FC; Chott A; Moretta L; Rüdiger T; Ott G; Müller-Hermelink HK
Blood; 2000 Jun; 95(11):3628-30. PubMed ID: 10828054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
